View in EDS

PCN24 - Duration of Treatment and Economic Burden in Patients with Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Receiving Second-Line Alk Inhibitors.

Saved in:
Bibliographic Details
Title: PCN24 - Duration of Treatment and Economic Burden in Patients with Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Receiving Second-Line Alk Inhibitors.
Authors: Lin, HM1, Hou, P1, Huang, H1, Desai, A1, Jahanzeb, M2
Source: Value in Health. 2018 Supplement 1, Vol. 21, pS17-S17. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 130501798
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PCN24 - Duration of Treatment and Economic Burden in Patients with Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Receiving Second-Line Alk Inhibitors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Lin%2C+HM%22">Lin, HM</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hou%2C+P%22">Hou, P</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Huang%2C+H%22">Huang, H</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Desai%2C+A%22">Desai, A</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Jahanzeb%2C+M%22">Jahanzeb, M</searchLink><relatesTo>2</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Value+in+Health%22">Value in Health</searchLink>. 2018 Supplement 1, Vol. 21, pS17-S17. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=130501798
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jval.2018.04.102
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S17
    Titles:
      – TitleFull: PCN24 - Duration of Treatment and Economic Burden in Patients with Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Receiving Second-Line Alk Inhibitors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lin, HM
      – PersonEntity:
          Name:
            NameFull: Hou, P
      – PersonEntity:
          Name:
            NameFull: Huang, H
      – PersonEntity:
          Name:
            NameFull: Desai, A
      – PersonEntity:
          Name:
            NameFull: Jahanzeb, M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 05
              Text: 2018 Supplement 1
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 10983015
          Numbering:
            – Type: volume
              Value: 21
          Titles:
            – TitleFull: Value in Health
              Type: main
ResultId 1